BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., announced the successful closing of its acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform. The acquisition adds an established operating platform with direct-to-consumer infrastructure, commercial operations, proprietary formulations, intellectual property, supplier relationships, inventory, fulfillment capabilities, digital marketing systems, customer acquisition infrastructure, and a diversified catalogue of more than 20 wellness SKUs already commercialized and in market. Management believes this represents a defining milestone in the Company's evolution into a scalable operating platform focused on wellness, performance, functional products, and human optimization.
The transaction follows a series of strategic developments completed by BFCH over the past year, including the elimination of more than $2 million in legacy convertible debt obligations, strengthening of the Company's balance sheet, restoration of disclosure compliance, acquisition of the EVERMIND™ intellectual property platform, and expansion of executive leadership. The Company is now actively transitioning Ancient Extracts into a broader commercialization and expansion phase focused on scaling both direct-to-consumer operations and retail distribution opportunities. BFCH confirmed it is advancing strategic growth capital initiatives designed to support inventory expansion, operational scaling, customer acquisition, retail channel development, and broader commercialization execution.
Management believes the completion of the acquisition significantly de-risks the Company's broader operating strategy by establishing an active commercial foundation upon which future growth initiatives can now be accelerated. With operating infrastructure, products, and customer acquisition systems already in place, the Company's focus is shifting toward securing and deploying strategic growth capital intended to fuel expanded distribution, customer acquisition, inventory scaling, retail penetration, and broader long-term platform expansion initiatives. The Company stated that it expects to begin announcing additional operational milestones, including retail initiatives, strategic partnerships, purchase order activity, and broader capital formation initiatives.
John P. Gorst, Chief Executive Officer of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value." Jordan P. Balencic, D.O., Chairman and Chief Science Officer, added: "Closing Ancient Extracts represents a transformational milestone for BFCH and UNLOCKD. Our focus now shifts from corporate restructuring and platform assembly toward commercialization, operational execution, strategic expansion, and long-term value creation."
The Company also confirmed that management continues actively evaluating additional acquisition opportunities, strategic partnerships, and commercialization initiatives aligned with its broader long-term strategy. Separately, BFCH recently received a formal legal opinion from securities counsel concluding that the Company is not a shell company under Rule 405 of the Securities Act of 1933 based upon its operating strategy, asset base, acquisitions, and ongoing operational activities. For more information, visit UNLOCKDinc.com and view current filings on OTC Markets.